‘My life was full of people telling me you can’t do this’: First sickle cell CRISPR gene therapy already rescuing lives

Victoria in hospital during her treatment. Credit: Victoria Gray.
Victoria in hospital during her treatment. Credit: Victoria Gray.

“My life was constantly full of ‘noes’, and people telling me ‘you can’t do this’ – it was limitation after limitation,” [Victoria Gray] says. “I had to alter everything I dreamed about, every step of the way from childhood to adulthood.”

If you’re lucky enough to grow up having a healthy childhood, it’s hard to imagine the cruel realities of experiencing a sick one. Victoria describes the motions of her life as though it was a distressing movie being played out in front of her, and someone – somewhere – kept hitting the pause button. Her days were shaped not by the whimsical imagination of a young child, but by her illness. That’s because at just three months of age she had been diagnosed with sickle cell disease (SCD).

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

In July 2019, she became the first patient to receive CRISPR gene therapy for SCD.

“The trial was a different experience to anything I’ve had before, because for the first time, I felt hopeful. I was fighting for my life, and for my family.” Sure, I had to travel back to Nashville a lot for testing, and there were times [during the trial], especially after the chemotherapy, that it was hard. But my dad was with me, and he kept reminding me, ‘Vicky, you’ve seen worse, you are strong enough to get through this’. It helped to lift me back up and remind me of why I was doing this.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-11-at-10.24.21-AM
Viewpoint: RFK Jr.’s new CDC head Erica Schwartz greenlights hepatitis B vaccine study critics call “unethical and designed to cast doubts on its safety”
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot 2026-10-12 at 12.25
Tearful onions? CRISPR has a solution for that
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.